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Fluprostenol-Induced MAPK Signaling Is Independent of Aging 
in Fischer 344/NNiaHSd x Brown Norway/BiNia Rat Aorta
Kevin M. Rice,1,2,3,4 Ernest M. Walker,5 Sunil K Kakarla,3,4,6 Satyanarayana Paturi,1,3,4 
Miaozong Wu,1,3 Sumit Narula,4 and Eric R. Blough1,2,3,4,6
1Department of Biological Sciences, 2Department of Exercise Science, Sport and Recreation, 3Cell 
Differentiation and Development Center, 4Laboratory of Molecular Physiology, 5Department of Anatomy 
and Pathology, and 6Department of Pharmacology, Physiology, and Toxicology, Marshall University, 
Huntington, West Virginia
Abstract. The factors that regulate vascular mechanotransduction and how this process may be altered 
with aging are poorly understood and have not been widely studied. Recent data suggest that increased 
tissue loading can result in the release of prostaglandin F2 alpha (PGF2α) and other reports indicate that 
aging diminishes the ability of the aged aorta to activate mitogen activated protein kinase (MAPK) signaling 
in response to increased loading. Using ex vivo incubations, here we investigate whether aging affects the 
ability of the aorta to induce phosphorylation of extracellular signal-regulated kinase 1/2 (ERK½-MAPK), 
p38-MAPK, and Jun N-terminal kinase (JNK-MAPK) activation following stimulation with a PGF2α 
analog, fluprostenol. Compared to aortas from 6-mo animals, the amounts of ERK½- and p38-MAPK 
remained unchanged with aging, while the level of JNK-MAPK protein increased by 135% and 100% at 
30- and 36-mo, respectively. Aging increased the basal phosphorylation of ERK½ (115% and 47%) and 
JNK (29% and 69%) (p <0.05) in 30- and 36-mo aortas, while p38 phosphorylation levels remained 
unaltered. Compared to age-matched controls, fluprostenol induced phosphorylation of ERK½ (310%, 
286%, and 554%), p38-MAPK (unchanged, 48%, and 148%), and JNK (78%, 88%, and 95%) in 6-, 30- 
and 36-mo aortas, respectively. These findings suggest that aging does not affect the ability of the rat aorta 
to activate ERK½-, p38-MAPK, and JNK-MAPK phosphorylation in response to PGF2α stimulation. 
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Introduction
Aging is the primary risk factor for cardiovascular 
disease (CVD). Although not well understood, it is 
thought that this increased risk may be due to age-
associated changes in cardiovascular structure and 
function. Recently we reported that stretching of 
aortic vascular smooth muscle cells (VSMC) 
activates mitogen activated protein kinase (MAPK) 
signaling and that this response is altered with 
aging in Fischer 344/NNiaHSd x Brown Norway 
/BiNia rat (F344BN) aortas [1]. Specifically, we 
demonstrated that aging is associated with decreased 
ability of the aged aorta to activate p38-MAPK and 
c-Jun N-terminal kinase (JNK) signaling. The 
factors that regulate load-induced signaling in the 
aorta and other tissues are not well understood. In 
addition to mechanical stimuli, the possibility 
exists that autocrine and paracrine factors may play 
roles [2,3]. For example, Vandenburgh et al. [4] 
demonstrated that mechanical stimulation of 
cultured skeletal muscle increases the synthesis of 
prostaglandin F2 alpha (PGF2α) and that this 
increase is associated with the regulation of protein 
turnover and muscle cell growth. Similarly, it has 
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recently been shown that PGF2α can induce 
hypertrophy of neonatal rat ventricular myocytes 
and VSMC in vitro [5-8]. Whether the differences 
in mechanically-induced signaling that we observed 
in the aging F344BN aorta are due to alterations in 
the ability of the aged aorta to respond to PGF2α 
is unknown.
 PGF2α receptor stimulation has been shown 
to induce MAPK activation in human endometrium 
epithelial cells [9] and cardiac myocytes [7]. The 
MAPK signaling network is composed of three 
homologous yet distinct kinase cascade pathways 
including the extracellular signal-regulated kinases 
(ERK)½, c-Jun NH2-terminal kinase (JNK), and 
p38 kinase [10].  Studies in rats and humans have 
implicated the activation (phosphorylation) of 
MAPK signaling in the regulation of protein 
synthesis, mRNA stability, as mediators of apoptosis 
and the inflammatory response, and as key players 
in the control of load-induced alterations in protein 
expression [11-14]. Whether aging affects the ability 
of VSMC to activate MAPK signaling in response 
to PGF2α stimulation is not well understood. 
 Here we investigate if aging affects the ability 
of the aorta to respond to PGF2α by subjecting 
isolated aortas to a PGF2α analog, fluprostenol 
(FP). Our data demonstrate that fluprostenol 
activates ERK½, JNK, and p38-MAPK in aorta, 
and that fluprostenol-induced phosphorylation of 
MAPKs increases with aging. The data suggest that 
stretch-induced MAPK activation in the aging 
aorta is not associated with an inability of the aged 
aorta to respond to PGF2α. 
Materials and Methods
Animals. All procedures were in accordance with the Guide 
for the Care and Use of Laboratory Animals as approved by 
the Council of the American Physiological Society and the 
Animal Use Review Board of Marshall University. All 
procedures were in accordance with the Public Health Service 
animal welfare policy. Adult (6-mo), aged (30-mo), and very 
aged (36-mo) male Fischer 344 /NNiaHSd x Brown Norway 
/BiNia (F344BN) rats were obtained from the National 
Institute on Aging (NIA) and were barrier-housed (2 rats/
cage) in an AAALAC approved vivarium. Housing conditions 
consisted of 12 hr/12 hr dark-light cycle and a room 
temperature of 22 ± 2˚C. The rats were provided food and 
water ad libitum. Rats were allowed to recover from shipment 
for at least two weeks before experimentation, during which 
time the rats were observed and weighed weekly. None of the 
older rats exhibited signs of failure to thrive, such as precipitous 
weight loss, disinterest in the environment, or unexpected 
gait alterations.
Materials. Antibodies against p38-MAPK (#9212), phospho-
p38-MAPK (Thr180/Tyr182) (p-p38-MAPK, #9216), extra-
cellular-regulated kinase 1/2 (ERK1/2, #9102), phospho-
ERK1/2 (Thr202/Tyr204) (p-ERK1/2, #4377), c-Jun 
N-terminal kinase 1/2 (JNK1/2, #9252), phospho-JNK1/2 
(Thr183/Tyr185) (p-JNK1/2, #9251), mouse IgG (#7076), 
and rabbit IgG (#7074) were from Cell Signaling Technology 
(Beverly, MA). Precast 7.5%, 10%, and 15% SDS-PAGE gels 
were from Cambrex Biosciences (Baltimore, MD). Enhanced 
chemiluminescent (ECL) western blot detection reagent was 
from Amersham Biosciences (Piscataway, NJ). Restore 
western blot stripping buffer was from Pierce (Rockford, IL). 
3T3 cell lysates were from Santa Cruz Biotechnology (Santa 
Cruz, CA). Fluprostenol and all other chemicals were from 
Sigma (St. Louis, MO). 
Artery preparation and ex vivo incubations. Rats were 
anesthetized with a ketamine-xylazine (4:1) cocktail (50 mg/
kg ip) and supplemented as necessary for reflexive response. 
In a sterile, aseptic environment, the ventral surface of the 
thorax was shaved and the superficial musculature was 
exposed by means of a transverse incision through the skin 
distal to the thoracic cavity. After midline laparotomy and 
perforation of the heart, the aorta was isolated and removed 
from the left ventricle to the renal arch. Isolated aortas were 
cleansed of connective tissue, transected at the subclavian 
artery and the diaphragmatic insertion, and cut longitudinally. 
The vessel segment was denuded and allowed to equilibrate in 
oxygenated Krebs-Ringer bicarbonate (KRB) buffer at 37˚C 
for 1 hr. Vessels were incubated for 30 min with vehicle 
(ethanol) or 1 µM fluprostenol, on the basis of a previous 
finding that this concentration of fluprostenol is sufficient to 
induce intracellular signaling and myocyte hypertrophy [7]. 
Following incubations, vessels were collected and snap frozen 
in liquid nitrogen. All vessel handling was done in oxygenated 
KRB buffer maintained at 37˚C. 
Immunoblotting. Samples were pulverized with liquid 
nitrogen and lysed on ice for 30 min in T-PER (2 ml/g tissue) 
(Pierce, Rockford, IL) supplemented with 100 mM NaF, 1 
mM Na3VO4, 2 mM PMSF, 1 µg/ml aprotinin, 1 µg/ml 
leupeptin, and 1 µg/ml pepsatin. After lysis, homogenates 
were centrifuged 10 min at 10,000 rpm and the supernatants 
collected. Protein concentrations of the supernates were 
determined in triplicate using the Bradford method (Pierce, 
Rockford, IL) with bovine serum albumin as a standard. 
Samples were diluted to a concentration of 1.5 mg/ml in SDS 
loading buffer, boiled for 5 min, and 30 µg of protein was 
analyzed using SDS-PAGE. Transfer of protein onto nitro-
cellulose membranes was performed using standard conditions 
[9] and equal loading between lanes and membranes was 
verified by staining the membranes with Ponceau S. For 
immunodetection, membranes were blocked with a solution 
of 5% nonfat dry milk prepared in Tris-buffered saline 
containing 0.1% Tween 20 (TBST) for 1 hr at room 
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temperature and then incubated with the appropriate primary 
antibody overnight. After washing in TBST, the membranes 
were exposed to horseradish peroxidase-labeled (HRP) IgG 
secondary antibody (1 hr at room temperature). 
 Protein bands were visualized with ECL (Amersham 
Biosciences). Exposure time was adjusted to keep the 
integrated optical densities (IODs) within a linear and non-
saturated range, and band signal intensity was quantified by 
densitometry using a flatbed scanner (Epson Pefection 3200 
PHOTO) and imaging software (AlphaEaseFC). Molecular 
weight markers (Cell Signaling) were used as molecular mass 
standards and NIH 3T3 cell lysates were included as positive 
controls. 
Data Analysis. Results are reported as mean ± SE. Data were 
analyzed using SigmaStat 3.0. Multiple group comparisons 
were performed by one-way ANOVA followed by Student-
Newman-Keuls post hoc test to determine differences between 
groups. The level of significance accepted was p <0.05. 
Results
Aging effects on basal expression of JNK. To 
determine whether aging influences the total 
protein levels of ERK½-, p38-MAPK, and JNK 
present in the aorta, immunoblot analyses were 
performed using antibodies that recognize both 
the unphosphorylated and phosphorylated forms 
of the proteins. The Western blots failed to show 
any significant changes in the expression of ERK½ 
and total p38-MAPK with aging (Fig. 1). Compared 
to 6-mo animals, the amount of JNK was 135 ± 
5% and 100 ± 6% higher in 30- and 36-mo aortas, 
respectively (p <0.05). 
Age-associated alterations of MAPK basal 
phosphorylation in aorta. Because ERK½, JNK, 
and p38-MAPK are thought to be regulated by 
phosphorylation, it was of interest to determine if 
the basal phosphorylation status of these proteins is 
altered with aging. When compared to 6-mo aortas, 
ERK½ phosphorylation was increased by 115 ± 5% 
and 47 ± 8% at 30- and 36-mo, respectively (p 
<0.05) (Fig. 2). JNK phosphorylation was increased 
by 29 ± 9% and 70 ± 5% at 30- and 36-mo (p 
<0.05) (Fig. 4). Conversely, basal phosphorylation 
of p38-MAPK was unaltered with aging (Fig. 3).
 
Fluprostenol-induced MAPK phosphorylation in 
aorta. PGF2α primarily mediates its cellular effects 
by binding with high affinity (Ki = 2.4 nM) to the 
FP prostanoid receptor [10]. To investigate the 
Fig. 1. Expression of ERK½, p38-MAPK, and JNK in aortas 
from 6-mo (young adult), 30-mo (aged) and 36-mo (very 
aged) Fischer 344/Brown Norway F1 hybrid rats. Relative 
changes in protein levels were determined by immunoblotting. 
The data are presented as fold-increase over the 6-mo value (n 
= 4). An asterisk indicates significant difference from the 
corresponding 6-mo value (p < 0.05).
Fig. 2. Basal (control) and fluprostenol-induced phosphoryl-
ation of ERK½ in aortas from 6-, 30- and 36-mo old rats. 
Results were obtained by Western blot with immunodetection 
of ERK½ phosphorylated at Thr202/Tyr204. An asterisk or 
cross indicates significant difference from the control or the 
corresponding 6-mo value, respectively (p < 0.05), n = 4.
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signaling evoked by FP receptor activation we 
stimulated rat aortic smooth muscle with the 
PGF2α receptor agonist, fluprostenol. Fluprostenol 
was chosen as an agonist because it has a similar 
affinity for the fluprostenol receptor as PGF2α (Ki 
= 3.8 nM) but does not bind to other prostanoid 
receptors. As shown in Figs. 2, 3, and 4, incubation 
with fluprostenol increased phosphorylated levels 
of MAPKs. Compared to unstimulated controls, 
the phosphorylation of ERK½ was increased 310 ± 
36%, 286 ± 51%, and 554 ± 38% at 6- , 30- and 
36-mo, respectively (p <0.05) (Fig. 2). Similarly, 
fluprostenol increased JNK phosphorylation by 78 
± 4%, 88 ± 6%, and 95 ± 14% at 6-, 30- and 36-
mo, respectively (p <0.05) (Fig. 4). Conversely, 
fluprostenol failed to affect p38-MAPKMAPK 
phosphorylation in 6-mo animals (Fig. 3), while in 
30- and 36-mo animals the stimulation increased 
p38-MAPK phosphorylation by 48 ± 6% and 148 
± 16% (p <0.05), respectively (Fig. 3). 
Discussion
In adult tissues, the mechanisms regulating ERK½, 
p38-MAPK, and JNK activation by mechanical 
stress have been linked to stretch-induced release of 
nitric oxide (NO), arachidonic acid metabolites, 
and prostacyclin from the endothelial cells acting 
upon the VSMC [15-17] as well as PDGF, fibroblast 
growth factor, and ATP [18-23]. Previously we 
demonstrated that an acute elevation in loading 
pressure in vitro can increase the phosphorylation 
status of ERK½, p38-MAPK, and JNK in aortas 
of rats [1]. Importantly, we also demonstrated that 
aging reduced the ability of the aorta to activate 
p38-MAPK and JNK proteins. These data suggest 
that aging alters the ability of the aorta to “sense” 
and “respond” to mechanical stimuli. 
 One finding of the present study is that aging 
appears to increase JNK expression in aorta (Fig. 
1). A similar increase in the amount of JNK-MAPK 
with aging was demonstrated previously in the 
aging F344BN aorta [24]. It is unclear why aging 
may increase the expression of JNK. It is thought 
that the JNK is a “stress kinase” [25,26]. Recent 
data suggest that aging may be associated with 
increases in the amount of reactive oxygen species 
(ROS) [24,27,28]. Whether this age-related increase 
Fig. 3. Basal (control) and fluprostenol-induced phosphoryl-
ation of p38-MAPK in aortas from 6-, 30-, and 36-mo old 
rats. Results were obtained by Western blot with immuno-
detection of p38 phosphorylated at Thr180/Tyr182. An 
asterisk or cross indicates significant difference from the 
control or the corresponding 6-mo value, respectively (p 
<0.05), n = 4.
Fig. 4. Basal (control) and fluprostenol-induced phosphoryl-
ation of JNK-MAPK in aortas from 6-, 30- and 36-mo old 
rats. Results were obtained by Western blot with immuno-
detection of JNK phosphorylated at Thr183/Tyr185. An 
asterisk or cross indicates significant difference from the 
control or the corresponding 6-mo value, respectively (p 
<0.05), n = 4.
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in ROS is related to changes in JNK expression is 
not known. JNK phosphorylates numerous proteins 
that reside in mitochondria or act within nuclei. 
This phosphorylation modifies the activity of these 
proteins allowing JNK activity to regulate several 
important cellular functions. Inflammatory signals, 
changes in levels of ROS, ultraviolet radiation, 
protein synthesis inhibitors, and a variety of stress 
stimuli have been shown to activate JNK. 
 Muscle stretch or loading has been shown to 
induce the release of PGF2α, which has a potential 
to activate MAPK proteins [29]. Whether aging 
affects the ability of the aorta to respond to PGF2α 
and whether this effect, if present, could help to 
explain differences in the ability of the aged aorta 
to “respond” to increases in loading is unknown. In 
the present study, we found that fluprostenol can 
activate MAPK proteins in the intact rat aorta 
(Figs. 2, 3, 4), which is consistent with previous 
data using cultured VSMC cells [30,31] and other 
work utilizing porcine carotid arteries [9].
 The ability of fluprostenol-induced phosphoryl-
ation of MAPK proteins is retained in the aged 
F344BN rat aortas. Compared to 6-mo rats, FP-
induced phosphorylation of both the ERK½ and 
JNK proteins in aged aorta was similar (Figs. 3, 4). 
Nonetheless, it should be noted that age-associated 
differences in the fluprostenol response appear to 
exist. Whereas fluprostenol stimulation fails to 
elicit phosphorylation of p38 in the 6-mo aortas, a 
marked increase in the amount of p38-MAPK 
phosphorylation was observed in 30- and 36-mo 
aortas (Fig. 2). The mechanism of this age-related 
difference in p38-MAPK activation is unknown. 
 In conclusion, our data suggest that aging does 
not diminish the ability of the aorta to activate 
MAPK proteins in response to fluprostenol 
stimulation. This finding is consistent with the 
possibility that age-related changes in the ability of 
the aorta to undergo MAPK activation in response 
to increased loading is not due to an inability of the 
aged aorta to respond to PGF2α. Nonetheless, it 
should be noted that it is not known if aging affects 
the amount of PGF2α generated upon aortic 
stretch. It is also unknown if aging alters PGF2α 
receptor density. Perhaps age-related decreases in 
PGF2α release or receptor density could help to 
explain why aortic mechanotransduction may be 
altered with aging. Further experiments will be 
useful in addressing these limitations. 
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